Schöckel, Leah
Woischke, Christine
Surendran, Sai Agash
Michl, Marlies
Schiergens, Tobias
Hölscher, Andreas
Glass, Florian
Kreissl, Peter
Klauschen, Frederick
Günther, Michael
Ormanns, Steffen
Neumann, Jens
Article History
Received: 9 October 2023
Accepted: 8 February 2024
First Online: 20 February 2024
Declarations
:
: This study was carried out according to the recommendations of the ethics committee of the Medical Faculty of the Ludwig-Maximilians-University Munich, Germany (project number: 20–104). The current study has been performed in a retro-spective manner in a cohort of patients diagnosed and treated according to national guidelines. In addition, the data set as well as the specimens were irreversibly anonymized prior to inclusion in the study. Hence, under the circumstances aforementioned, neither a written consent nor a project specific approval by the ethic committee was necessary. The study was performed according to the standards set in the declaration of Helsinki 1975. All researchers were blinded from patient data during experimental analysis.
: Not applicable.
: JN is senior editorial board member of BMC Cancer. LS no conflicts of interest. CW no conflicts of interest. MM no conflicts of interest. TS no conflicts of interest. SAS no conflicts of interest. PK no conflicts of interest. AH no conflicts of interest. FG no conflicts of interest. FK no conflicts of interest. MG no conflicts of interest. SO no conflicts of interest.